Clinical trial
Lipopolysaccharide Binding Protein as a Potential Biomarker of Parkinson's Disease
NCT01904240 is registered in ClinicalTrials.gov with Rush University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Lipopolysaccharide Binding Protein as a Potential Biomarker of Parkinson's Disease
- Lead sponsor
- Rush University Medical Center
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 31, 2013
- Completion date
- June 30, 2014
- Enrollment
- 200 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
parkinson's disease